Rusan Pharma is a Manufacturer/Innovator company operating in the pharmaceutical industry.
Rusan Pharma is an integrated pharmaceutical company manufacturing and marketing a wide range of active ingredients, finished dosage forms. Rusan is a major player in CRAMS and in contract manufacturing finished formulations for various companies in Europe. Rusan’s facilities have WHO-GMP, UK MHRA, SOUTH AFRICA-MCC approvals with state-of-the-art QC labs. Rusan recently acquired registration for Buprenorphine Hydrochloride Sublingual Tablets for Europe and has licensed it in many EU countries. Rusan has CEP for various molecules viz; Buprenorphine HCl/Base, Fentanyl, Naltrexone and has filed e- DMF for Naloxone, Methadone & Bisoprolol. Rusan’s niche lies in Opioid De-Addiction, severe pain management & anti-tuberculosis.
Company type
Manufacturer/Innovator
Products and services
APIs (Active Pharmaceutical Ingredients)
Markets
Oceania, Africa, Middle East Region (e.g. UAE), East Asia (e.g. China, Japan, Korea), Europe – EU countries, Europe – non EU (e.g. UK, Russia, ex-CIS countries), South Asia (e.g. India, Pakistan, Sri Lanka), South East Asia (e.g. Thailand, Philippines, Singapore)
Address
Rusan Pharma, 58 D Govt. Ind. Estate,Charkop, Kandivili (W), Mumbai, India, 400067
